SSIC 721 RESEARCH AND EXPERIMENTAL DEVELOPMENT ON NATURAL SCIENCES AND ENGINEERING
Companies in This Category (11,665)
LATTIQ LABS PTE. LTD.
Incorporated May 2026
SSIC: 721
Live Company
TUNDRY PTE. LTD.
Incorporated May 2026
SSIC: 721
Live Company
SINGAPORE NEXSOAR TECHNOLOGY PTE. LTD.
Incorporated May 2026
SSIC: 721
Live Company
TARIM THERAPEUTICS PTE. LTD.
Incorporated May 2026
SSIC: 721
Live Company
HEALTHPLATFORM.AI PTE. LTD.
Incorporated May 2026
SSIC: 721
Live Company
COGNIS AI PTE. LTD.
Incorporated May 2026
SSIC: 721
Live Company
GUERRILLA STUDIOS LLP
Incorporated May 2026
SSIC: 721
Live
GLOBAAC PTE. LTD.
Incorporated May 2026
SSIC: 721
Live Company
ROMULUS THERAPEUTICS PTE. LTD.
Incorporated May 2026
SSIC: 721
Live Company
KPNEO PRIVATE LIMITED
Incorporated May 2026
SSIC: 721
Live Company
AEROFLUX MEMBRANE PTE. LTD.
Incorporated May 2026
SSIC: 721
Live Company
EDGECORTIX TECHINOLOGY PTE. LTD.
Incorporated May 2026
SSIC: 721
Live Company
🔒 Free Preview:
You're viewing the first page of results
Related Categories (1)
Understanding SSIC 721
The SSIC 721 classification pertains to research and experimental development on natural sciences and engineering. This official code is mandatory when registering a business entity with ACRA (Accounting and Corporate Regulatory Authority) in Singapore.
Key Characteristics:
- Compliance with Section 171 of the Companies Act regarding financial reporting, particularly related to R&D expenditure.
- Often structured as a private limited company (Pte Ltd) to attract funding and limit liability.
- Subject to requirements under the Research, Innovation and Enterprise (RIE) 2025 plan, potentially impacting grant eligibility and reporting.
Common Business Operations
Research and experimental development on natural sciences and engineering.
Conducting laboratory research on new materials for construction, a common activity supported by the Building and Construction Authority (BCA).
Developing and testing prototypes for new medical devices, as classified under ACRA's guidelines for healthcare-related R&D.
Engaging in experimental development of software algorithms for fintech applications, aligning with the Monetary Authority of Singapore (MAS)'s focus on financial innovation.